Search

Your search keyword '"ADC Therapeutics S.A. -- Forecasts and trends"' showing total 6 results
Start Over Descriptor "ADC Therapeutics S.A. -- Forecasts and trends" Journal pr newswire
6 results on '"ADC Therapeutics S.A. -- Forecasts and trends"'

1. Antibody-Drug Conjugates Market to Grow at 28.4% CAGR from 2024 to 2029

Subjects
ADC Therapeutics S.A. -- Forecasts and trends, Biopharmaceutics -- Forecasts and trends, Viral antibodies -- Forecasts and trends, Antibodies -- Forecasts and trends, Industrial research -- Switzerland -- United Kingdom, Pharmaceutical industry -- Forecasts and trends, Research and development, Market trend/market analysis, Business, News, opinion and commentary
Abstract

'With 13 Commercially Available Products Globally and More than 200 in Clinical Trials, ADC Market is Set to Grow Exponentially' BOSTON, Oct. 21, 2024 /PRNewswire/ -- 'According to the latest [...]

Published
2024

2. Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market size is set to grow by USD 2.24 billion from 2024-2028, Growing geriatric population boost the market, Technavio

Subjects
ADC Therapeutics S.A. -- Forecasts and trends, Amgen Inc. -- Forecasts and trends, Bayer AG -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Biological products industry -- Forecasts and trends, Patient compliance -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, Lymphomas -- Forecasts and trends, Vincristine -- Forecasts and trends -- Market size, Radiotherapy -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

NEW YORK, June 27, 2024 /PRNewswire/ -- The global diffuse large B-cell lymphoma (DLBCL) therapeutics market size is estimated to grow by USD 2.24 billion from 2024-2028, according to Technavio. [...]

Published
2024

3. Antibody Drug Conjugates (ADC) Market worth $19.8 billion | MarketsandMarkets

Subjects
ADC Therapeutics S.A. -- Forecasts and trends, Biopharmaceutics -- Statistics, Independent regulatory commissions -- Forecasts and trends -- Statistics, Antineoplastic agents -- Statistics, Monoclonal antibodies -- Statistics -- Forecasts and trends, Pharmaceutical industry -- Statistics -- Forecasts and trends, Antimitotic agents -- Statistics, Market trend/market analysis, Business, News, opinion and commentary
Abstract

CHICAGO, Oct. 5, 2023 /PRNewswire/ -- The Antibody Drug Conjugates (ADC) industry represents a cutting-edge and rapidly evolving sector within the field of biopharmaceuticals. ADCs are a class of targeted [...]

Published
2023

4. Acute Lymphocytic Leukemia Market to Accelerate Substantially by 2032, Assesses DelveInsight | Key Companies in the Market - Beam, Pfizer, Genentech, AbbVie, Fate, Roche, Ascentage, Janssen, Jazz, ADC, Kymera, Syndax, ImmunoGen

Subjects
ADC Therapeutics S.A. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Oncology Inc. -- Forecasts and trends, Oncology, Experimental -- Forecasts and trends, Biological products industry -- Forecasts and trends, Patient compliance -- Forecasts and trends, Antineoplastic agents -- Forecasts and trends, Antigens -- Forecasts and trends, Acute lymphocytic leukemia -- Forecasts and trends, Cancer -- Research, Pharmaceutical industry -- Forecasts and trends, Antimitotic agents -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

The dynamics of the acute lymphocytic leukemia market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, rising awareness of the disease, incremental [...]

Published
2023

5. Bladder Cancer Clinical Trial Pipeline Insights Featuring 100+ Companies | DelveInsight

Subjects
ADC Therapeutics S.A. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Seagen Inc. -- Forecasts and trends, Business -- Research, BCG vaccines -- Forecasts and trends -- Reports, BCG -- Forecasts and trends -- Reports, Bladder cancer -- Forecasts and trends -- Reports, Cancer -- Care and treatment, Clinical trials -- Forecasts and trends -- Reports, Market trend/market analysis, Business, News, opinion and commentary
Abstract

DelveInsight's bladder cancer pipeline report depicts a robust space with 100+ active players working to develop 100+ pipeline therapies for bladder cancer treatment. LAS VEGAS, Aug. 23, 2022 /PRNewswire/ -- [...]

Published
2022

6. Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market Size to Grow by USD 1.79 billion, AbbVie Inc. and Bayer AG Among Key Vendors - Technavio

Subjects
Merck & Company Inc. -- Forecasts and trends, Spectrum Pharmaceuticals Inc. -- Forecasts and trends, ADC Therapeutics S.A. -- Forecasts and trends, Amgen Inc. -- Forecasts and trends, Bayer AG -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, Non-Hodgkin's lymphomas -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

NEW YORK, July 25, 2022 /PRNewswire/ -- DLBCL is a cancer of B-lymphocytes and is the most common type of Non-Hodgkins Lymphoma (NHL) among adults. It is a fast-growing and [...]

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results